Detalhe da pesquisa
1.
Impact of severe acute respiratory syndrome coronavirus-2 infection on the outcome of primary central nervous system lymphoma treatment: A study of the International PCNSL Collaborative Group.
Br J Haematol
; 199(4): 507-519, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35945164
2.
A dose-dense short-term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high-risk Burkitt lymphoma or high-grade B-cell lymphoma: safety and efficacy results of the "CARMEN" phase II trial.
Br J Haematol
; 192(1): 119-128, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33085777
3.
MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study.
Br J Haematol
; 193(3): 497-505, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33620087
4.
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma.
Blood
; 134(3): 252-262, 2019 07 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31118164
5.
Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation.
Hematol Oncol
; 38(3): 257-265, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32356913
6.
IELSG40/CLEO phase II trial of clarithromycin and lenalidomide in relapsed/refractory extranodal marginal zone lymphoma.
Haematologica
; 108(6): 1671-1675, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36546422
7.
Risk-tailored CNS prophylaxis in a mono-institutional series of 200 patients with diffuse large B-cell lymphoma treated in the rituximab era.
Br J Haematol
; 168(5): 654-62, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25312994
8.
Anti-CD38 monoclonal antibody impairs CD34+ mobilization and affects clonogenic potential in multiple myeloma patients.
Blood Transfus
; 2024 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38315530
9.
IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma.
Blood Adv
; 8(6): 1541-1549, 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38181782
10.
Clarithromycin as a "repurposing drug" against MALT lymphoma.
Br J Haematol
; 182(6): 913-915, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28771670
11.
Autoimmune haemolytic anaemia in mantle cell lymphoma : an insidious complication associated with leukemic disease.
Hematol Oncol
; 35(1): 135-137, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26078106
12.
Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma.
Blood Adv
; 6(22): 5811-5820, 2022 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35580327
13.
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study.
Blood Adv
; 6(1): 327-338, 2022 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34644385
14.
Treatment of MALT lymphoma of the conjunctiva with intralesional rituximab supplemented with autologous serum.
Blood Adv
; 4(6): 1013-1019, 2020 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32182364
15.
Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: final results of a phase 2 trial.
Blood Adv
; 4(15): 3648-3658, 2020 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32766857
16.
Ocular adnexal marginal zone lymphoma: Clinical presentation, pathogenesis, diagnosis, prognosis, and treatment.
Best Pract Res Clin Haematol
; 30(1-2): 118-130, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28288706
17.
Lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for autologous stem cell transplantation: an open label, single-arm, multicentre phase 2 trial.
Lancet Haematol
; 4(3): e137-e146, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28219694
18.
Hematoma-like primary cutaneous peripheral T-cell lymphoma: a rare clinical presentation.
Ital J Dermatol Venerol
; 156(Suppl. 1 to No. 6): 91-92, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32057216
19.
Imatinib does not substantially modify the glycemic profile in patients with chronic myeloid leukaemia.
Leuk Res
; 34(1): e5-7, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19717189